These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2822984)

  • 1. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis].
    Suzuki H; Suzuki M; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum immunoreactive prolyl hydroxylase in liver disease.
    Tuderman L; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1977 Dec; 7(6):537-41. PubMed ID: 204493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of serum prolyl hydroxylase beta-subunit levels determined using monoclonal antibody].
    Yasuhara M; Matsuda Y; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1225-32. PubMed ID: 2822982
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
    Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A histological examination of liver fibrosis and tissue prolyl hydroxylase in various liver diseases].
    Okada H
    Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1079-88. PubMed ID: 2552196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of prolyl hydroxylase analysis in clinical tests].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1989 Dec; 48 Suppl():321-3. PubMed ID: 2560079
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differences in changes of two serum markers of hepatic fibrogenesis in acute hepatitis].
    Matsuda Y; Yasuhara M; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Aug; 84(8):1631-8. PubMed ID: 2826851
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease.
    Mann SW; Fuller GC; Rodil JV; Vidins EI
    Gut; 1979 Oct; 20(10):825-32. PubMed ID: 230128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum 7S collagen in various liver diseases.
    Yamada S; Suou T; Kawasaki H; Yoshikawa N
    Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis.
    Fabris C; Falleti E; Federico E; Toniutto P; Pirisi M
    Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():151-5. PubMed ID: 9133247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hepatic injury on prolyl 3-hydroxylase and 4-hydroxylase activities in rat liver and on immunoreactive prolyl 4-hydroxylase concentrations in the liver and serum.
    Risteli J; Tuderman L; Tryggvason K; Kivirikko KI
    Biochem J; 1978 Jan; 170(1):129-35. PubMed ID: 204299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase.
    Kuutti-Savolainen ER; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1979 Feb; 9(1):89-95. PubMed ID: 222594
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic fibrosis and its serum markers].
    Okabe K
    Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of hepatic fibrosis.
    Plebani M; Burlina A
    Clin Biochem; 1991 Jun; 24(3):219-39. PubMed ID: 1651819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic prolyl hydroxylase activity in human liver disease.
    McPhie JL
    Hepatogastroenterology; 1980 Aug; 27(4):277-82. PubMed ID: 6259037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new determination method of type IV collagen in sera and its clinical significance in relation to hepatic fibrosis].
    Suzuki H; Suzuki M; Kato Y; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1988 Aug; 85(8):1569. PubMed ID: 2846928
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.
    Torres-Salinas M; Parés A; Caballería J; Jiménez W; Heredia D; Bruguera M; Rodés J
    Gastroenterology; 1986 May; 90(5 Pt 1):1241-6. PubMed ID: 3007261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum immunoreactive prolyl hydroxylase in rats with carrageenan-induced granuloma and adjuvant arthritis.
    Matsumoto E; Muragaki Y; Ooshima A; Terasawa M; Imayoshi T
    Exp Mol Pathol; 1988 Oct; 49(2):243-53. PubMed ID: 2844581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.